Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI North America CPhI North America
Not Confirmed
Not Confirmed
20-22 May, 2025
STLE Annual MeetingSTLE Annual Meeting
Not Confirmed
Not Confirmed
18-22 May, 2025
American Thoracic Soci...American Thoracic Society
Not Confirmed
Not Confirmed
18-21 May, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI North America CPhI North America
Industry Trade Show
Not Confirmed
20-22 May, 2025
STLE Annual MeetingSTLE Annual Meeting
Industry Trade Show
Not Confirmed
18-22 May, 2025
American Thoracic Soci...American Thoracic Society
Industry Trade Show
Not Confirmed
18-21 May, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/dmf-filings-surge-44-in-q1-2025-india-tops-list-with-51-rise-in-year-on-year-submissions
20 Mar 2025
// BIOSPACE
https://www.biospace.com/deals/black-diamond-nabs-solid-tumor-asset-in-up-to-780m-deal-with-servier
19 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/19/3045227/0/en/Servier-and-Black-Diamond-Therapeutics-Announce-Global-Licensing-Agreement-for-BDTX-4933-A-Targeted-Oncology-Therapy.html
04 Mar 2025
// BUSINESSWIRE
04 Feb 2025
// CONTRACTPHARMA
https://www.contractpharma.com/breaking-news/servier-adopts-veeva-rim/
16 Jan 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/servier-and-google-cloud-expand-partnership-on-using-data-and-ai-302352283.html
09 Jan 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/servier-announces-expansion-of-its-tibsovo-ivosidenib-development-program-investigating-its-safety-and-efficacy-in-patients-living-with-idh1-mutated-cancers-in-both-hematological-malignancies-and-solid-tumors-302347478.html
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 27980
Submission : 2014-03-14
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 27981
Submission : 2014-03-14
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 10106
Submission : 1993-02-26
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 8577
Submission : 1990-05-21
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 27979
Submission : 2014-03-14
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 27822
Submission : 2014-01-21
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 9171
Submission : 1991-06-10
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 8576
Submission : 1990-05-21
Status : Inactive
Type : II
RLD :
TE Code :
Dosage Form : INJECTABLE; INTRAVENOUS
Proprietary Name : ASPARLAS
Dosage Strength : 3750UNITS/5ML
Approval Date :
Application Number : 761102
RX/OTC/DISCN :
RLD :
TE Code :
RLD : Yes
TE Code :
Dosage Form : TABLET; ORAL
Proprietary Name : TIBSOVO
Dosage Strength : 250MG
Approval Date : 2018-07-20
Application Number : 211192
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
RLD : Yes
TE Code :
Dosage Form : TABLET; ORAL
Proprietary Name : VORANIGO
Dosage Strength : 10MG
Approval Date : 2024-08-06
Application Number : 218784
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
RLD : Yes
TE Code :
Dosage Form : TABLET; ORAL
Proprietary Name : VORANIGO
Dosage Strength : 40MG
Approval Date : 2024-08-06
Application Number : 218784
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
Services
Packaging
API Manufacturing
Drug Product Manufacturing
Analytical
API & Drug Product Development
Inspections and registrations
ABOUT THIS PAGE
Servier is a supplier offers 15 products (APIs, Excipients or Intermediates).
Find a price of Indapamide bulk with CEP, JDMF offered by Servier
Find a price of Perindopril Erbumine bulk with CEP, JDMF offered by Servier
Find a price of Gliclazide bulk with CEP, JDMF offered by Servier
Find a price of Ivabradine Hydrochloride bulk with DMF, JDMF offered by Servier
Find a price of Captopril bulk with DMF offered by Servier
Find a price of Hexahydroazepine bulk with DMF offered by Servier
Find a price of Perindopril Arginine bulk with DMF offered by Servier
Find a price of Perindopril Erbumine bulk with CEP offered by Servier
Find a price of Rilmenidine Phosphate bulk with CEP offered by Servier
Find a price of Trimetazidine Hydrochloride bulk with JDMF offered by Servier
Find a price of Dexfenfluramine bulk offered by Servier
Find a price of Indapamide bulk offered by Servier
Find a price of FACILITIES AND OPERATING PROCEDURES IN BOLBEC, FRANCE bulk offered by Servier
Find a price of Agomelatine bulk offered by Servier
Find a price of Gliclazide bulk offered by Servier